These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24852111)

  • 1. Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review.
    Martin A; Krishna I; Badell M; Samuel A
    Prenat Diagn; 2014 Jul; 34(7):685-91. PubMed ID: 24852111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-Free Fetal DNA for the Prediction of Pre-Eclampsia at the First and Second Trimesters: A Systematic Review and Meta-Analysis.
    Contro E; Bernabini D; Farina A
    Mol Diagn Ther; 2017 Apr; 21(2):125-135. PubMed ID: 27838884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free nucleic acids as potential markers for preeclampsia.
    Hahn S; Rusterholz C; Hösli I; Lapaire O
    Placenta; 2011 Feb; 32 Suppl():S17-20. PubMed ID: 21257079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Free Fetal DNA: A Novel Biomarker for Early Prediction of Pre-eclampsia and Other Obstetric Complications.
    Kumar N; Singh AK
    Curr Hypertens Rev; 2019; 15(1):57-63. PubMed ID: 29766818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Serum sEndoglin and Cell-Free Fetal DNA as Probable Markers of Preeclampsia: A Study in Single Center, Egypt.
    Nabiel Y; Mosbah A
    Immunol Invest; 2019 Aug; 48(6):608-617. PubMed ID: 30794004
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.
    Karapetian АО; Baev ОR; Sadekova АА; Krasnyi АМ; Sukhikh GT
    Reprod Sci; 2021 May; 28(5):1563-1569. PubMed ID: 33475978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal DNA quantitation in peripheral blood is not useful as a marker of disease severity in women with preeclampsia.
    Byrne BM; Crowley A; Taulo F; Anthony J; O'Leary JJ; O'Herlihy C
    Hypertens Pregnancy; 2003; 22(2):157-64. PubMed ID: 12909000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.
    Levine RJ; Qian C; Leshane ES; Yu KF; England LJ; Schisterman EF; Wataganara T; Romero R; Bianchi DW
    Am J Obstet Gynecol; 2004 Mar; 190(3):707-13. PubMed ID: 15042003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal DNA in maternal plasma in preeclamptic pregnancies.
    Vlková B; Turňa J; Celec P
    Hypertens Pregnancy; 2015 Feb; 34(1):36-49. PubMed ID: 25291431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying mild and severe preeclampsia in asymptomatic pregnant women by levels of cell-free fetal DNA.
    Jakobsen TR; Clausen FB; Rode L; Dziegiel MH; Tabor A
    Transfusion; 2013 Sep; 53(9):1956-64. PubMed ID: 23320950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester maternal plasma cell-free fetal DNA and preeclampsia.
    Sifakis S; Zaravinos A; Maiz N; Spandidos DA; Nicolaides KH
    Am J Obstet Gynecol; 2009 Nov; 201(5):472.e1-7. PubMed ID: 19631923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of maternal serum cell-free fetal DNA in early-onset preeclampsia.
    Yu H; Shen Y; Ge Q; He Y; Qiao D; Ren M; Zhang J
    Int J Mol Sci; 2013 Apr; 14(4):7571-82. PubMed ID: 23567271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodies.
    Korabecna M; Ulcova-Gallova Z; Horinek A; Pazourková E; Calda P
    Autoimmunity; 2014 Nov; 47(7):473-7. PubMed ID: 24829103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia.
    Cotter AM; Martin CM; O'leary JJ; Daly SF
    Am J Obstet Gynecol; 2004 Aug; 191(2):515-20. PubMed ID: 15343229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free fetal DNA and pregnancy-related complications (review).
    Sifakis S; Koukou Z; Spandidos DA
    Mol Med Rep; 2015 Apr; 11(4):2367-72. PubMed ID: 25530428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the relation between concentration of circulating non-host fetal DNA in pregnant women and pre-eclampsia].
    Tao H; Wang XM; Ji XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):808-11. PubMed ID: 16412324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the female fetal DNA concentration in the plasma of the pregnant women as preeclampsia indicator--preliminary report.
    Karina E; Tomasz P; Bilar M; Agnieszka O; Ewa B; Elzbieta RW
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):165-8. PubMed ID: 19632756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a future for cell-free fetal dna tests in screening for preeclampsia?
    Sarzynska-Nowacka U; Kosinski P; Wielgos M
    Ginekol Pol; 2019; 90(1):55-60. PubMed ID: 30756372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell free fetal DNA in the plasma of pregnant women with preeclampsia.
    Seval MM; Karabulut HG; Tükün A; Koç A
    Clin Exp Obstet Gynecol; 2015; 42(6):787-91. PubMed ID: 26753487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.
    Zhong XY; Holzgreve W; Hahn S
    Hypertens Pregnancy; 2002; 21(1):77-83. PubMed ID: 12044339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.